RECRUITING

Effect of Group Preoperative Pelvic Floor Training for HoLEP

Description

The main goal of this study is to see if group pelvic floor training before surgery can help prevent urinary incontinence after Holmium laser enucleation of the prostate (HoLEP) surgery. The study has the potential to inform preoperative intervention strategies for managing incontinence after HoLEP.

Study Overview

Study Details

Study overview

The main goal of this study is to see if group pelvic floor training before surgery can help prevent urinary incontinence after Holmium laser enucleation of the prostate (HoLEP) surgery. The study has the potential to inform preoperative intervention strategies for managing incontinence after HoLEP.

The Effect of Group Preoperative Pelvic Floor Training on Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate: A Prospective Cohort Study

Effect of Group Preoperative Pelvic Floor Training for HoLEP

Condition
BPH
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California, San Francisco, San Francisco, California, United States, 94143

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Consecutive patients with a diagnosis of BPH with a plan to undergo HoLEP.
  • * Between the age of 50-90.
  • * Ability to understand and provide informed consent.
  • * Patients whom inability to carry out PFT protocol.
  • * Patients unwilling or unable to complete follow up care.
  • * Severe urinary incontinence due to a history of neurological diseases such as a cerebrovascular accident or spinal cord injuries.
  • * Patients whom inability to read and understand the English language.

Ages Eligible for Study

50 Years to 90 Years

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Thomas Chi, M.D., PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2026-03-30